Related Experiment Video

Updated: Jul 5, 2026

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
15:17

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Published on: September 25, 2011

[Antibody treatment in colorectal cancer--what the surgeon needs to know]

A Thalheimer1, B Illert, P Reimer

  • 1Chirurgische Klinik und Poliklinik I, Zentrum Operative Medizin der Universitätsklinik Würzburg. Thalheimer_S@chirurgie.uni-wuerzburg.de

Zentralblatt Fur Chirurgie
|April 17, 2008
PubMed

Insights

New targeted therapies, including monoclonal antibodies like cetuximab and bevacizumab, are improving colorectal cancer treatment. Combining these with traditional drugs offers advanced therapeutic options for patients with metastatic colorectal cancer.

Area of Science:

  • Oncology
  • Medical Biotechnology

Background:

  • Colorectal cancer treatment has advanced with new cytotoxic drugs.
  • Molecular and tumor biology progress yields targeted monoclonal antibodies.
  • Cetuximab and bevacizumab are approved for metastatic colorectal cancer.

Purpose of the Study:

  • To review advances in colorectal cancer treatment.
  • To discuss the role of monoclonal antibodies in therapy.
  • To highlight new therapeutic strategies for advanced disease.

Main Methods:

  • Review of current cytotoxic agents.
  • Analysis of molecular and tumor biology advancements.
  • Evaluation of approved monoclonal antibodies: cetuximab and bevacizumab.

Main Results:

  • New cytotoxic drugs have improved patient outcomes.
  • Targeted monoclonal antibodies show promise in clinical development.
  • Cetuximab (anti-EGFR) and bevacizumab (anti-VEGF) are approved for metastatic colorectal cancer.

Conclusions:

  • Combining cytotoxic agents with monoclonal antibodies increases treatment complexity.
  • These combined strategies provide additional therapeutic options for advanced colorectal cancer patients.

More Related Videos

Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis04:22

Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis

Published on: March 3, 2023

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...